Yongsong Chen
Overview
Explore the profile of Yongsong Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen L, Wu P, Zhu Y, Luo H, Tan Q, Chen Y, et al.
APL Bioeng
. 2025 Mar;
9(1):011501.
PMID: 40027546
The high incidence and prevalence of diabetic foot ulcers (DFUs) present a substantial clinical and economic burden, necessitating innovative therapeutic approaches. Fibroblasts, characterized by their intrinsic cellular plasticity and multifunctional...
2.
Lin K, Yao M, Andrew L, Lin R, Li R, Chen Y, et al.
Ann Fam Med
. 2025 Jan;
23(1):52-59.
PMID: 39805691
Purpose: This study aimed to examine the approaches general practitioners (GPs) use to respond to the treatment burden faced by people with type 2 diabetes. Methods: We retrospectively analyzed 29...
3.
Chen Y, Chen C, Chen W, Gai W, Zheng Y, Guo Y, et al.
Infect Drug Resist
. 2024 Oct;
17:4695-4706.
PMID: 39479400
Purpose: This study aimed to evaluate the clinical utility of metagenomic next-generation sequencing (mNGS) in sepsis patients who received early empirical antibiotic treatment. Patients And Methods: A retrospective analysis was...
4.
Lin K, Yao M, Ji X, Li R, Andrew L, Oosthuizen J, et al.
BMC Prim Care
. 2024 Jun;
25(1):206.
PMID: 38858619
Background: Measuring treatment burden is important for the effective management of Type 2 Diabetes Mellitus (T2DM) care. The purpose of this systematic review was to identify the most robust approach...
5.
Lin K, Yao M, Andrew L, Li R, Chen Y, Oosthuizen J, et al.
BMC Prim Care
. 2024 Mar;
25(1):88.
PMID: 38491369
Background: Understanding treatment burden is a critical element to the effective management of Type 2 Diabetes Mellitus (T2DM). The current study aims to address the knowledge gap surrounding treatment burden...
6.
Shi Y, Zhang Q, Zhang M, Chen Y, Sun J, Chen L, et al.
J Med Chem
. 2023 Apr;
66(8):5685-5702.
PMID: 37021456
In recent years, it has been proposed that G9a/EZH2 dual inhibition is a promising cancer treatment strategy. Herein, we present the discovery of G9a/EZH2 dual inhibitors that merge the pharmacophores...
7.
Xu H, Xu F, Lu H, Chen J, Huang X, Chen Y, et al.
Arch Med Res
. 2023 Mar;
54(4):277-286.
PMID: 36990889
Background: Chronic obstructive pulmonary disease and other respiratory inflammatory diseases are often associated with cigarette smoke exposure. However, the underlying molecular mechanism remains unclear. Aim Of The Study: This study...
8.
Wu Z, Zhang B, Chen F, Xia R, Zhu D, Chen B, et al.
Front Cell Infect Microbiol
. 2023 Jan;
12:1089991.
PMID: 36704100
Objectives: Recent studies have shown that fecal microbiota transplantation (FMT) improved the metabolic profiles of patients with type 2 diabetes mellitus (T2DM), yet the effectiveness in reversing insulin resistance and...
9.
Zheng Y, Yin G, Chen F, Lin L, Chen Y
Int J Womens Health
. 2022 Dec;
14:1821-1829.
PMID: 36582617
Purpose: To use the triglyceride glucose (TyG) index to evaluate insulin resistance (IR) in patients with polycystic ovary syndrome (PCOS) and to explore alternative indicators for early identification of IR....
10.
Yin G, Chen F, Chen G, Yang X, Huang Q, Chen L, et al.
J Ovarian Res
. 2022 Oct;
15(1):117.
PMID: 36303234
To characterize the gut bacteriome, mycobiome and serum metabolome profiles in polycystic ovary syndrome (PCOS) patients with normal/overweight individuals and evaluate a potential microbiota-related diagnostic method development for PCOS, 16S...